Cetuximab for metastatic colorectal cancer.
Roila
Fausto
F
Garassino
Marina Chiara
MC
Ballatori
Enzo
E
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D035843:Biomedical Research / Q000592:standards; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics; D018450:Disease Progression; D011905:Genes, ras; D006801:Humans; D009154:Mutation; D012189:Retrospective Studies
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab